Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat

American Journal of Pathology

Volumn 150, Issue 6, 1997, Pages 1909-1917

  Smith, Terence ^a   Hewson, Adrian K ^a   Kingsley, Cherry I ^a   Leonard, John P ^b   Cuzner, M Louise ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; RECOMBINANT INTERLEUKIN 12;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RAT; RELAPSE; T LYMPHOCYTE;

ANIMALS; BRAIN STEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERLEUKIN-12; MACROPHAGES; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; RECURRENCE; SPINAL CORD; T-LYMPHOCYTES;

EID: 0030944709     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Lassmann H, Zimprich F, Rossler K, Vass K: Inflammation in the nervous system: basic mechanisms and immunological concepts. Rev Neurol 1991, 147:763-781
2. Ben-Nun A, Cohen I: Experimental autoimmune encephalomyelitis (EAE) mediated by T-cell lines: process of selection of lines and characterization of the cells. J Immunol 1982, 129:303-308
3. Huitinga I, Van Roojien N, de Groot CJA, Uitdehaag BMJ, Dijkstra CD: Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990, 172:1025-1033
4. Powell MB, Mitchell D, Lederman J, Buchmeier J, Zamvil SS, Graham M, Ruddle NH, Steinman L: Lymphotoxin production by myelin basic protein specific T cell clones correlates with encephalitogenicity. Int Immunol 1990, 2:539-544
5. + T cell clones in the rat: cloning methodology and IFN-γ secretion. J Immunol Methods 1989, 143:3492-3497
6. Mossman TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173
7. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM: inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA 1992, 89:574-578
8. Issazadeh S, Ljungdahl A, Hojeberg B, Mustafa M, Olsson T: Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β. J Neuroimmunol 1995, 61:205-212
9. Issazadeh S, Mustafa M, Ljungdahl A, Hojeberg B, Eide R, Dagerlind A, Olsson T: Interferon-γ, interleukin-4, and transforming growth factor-β in experimental allergic encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res 1995, 40:579-590
10. Kennedy MK, Torrance DS, Picha KS, Mohler KM: Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992, 149:2496-2505
11. Smith T, Schmied M, Hewson AK, Lassmann H, Cuzner ML: Apoptosis of T cells and macrophages in the central nervous system of intact and adrenalectomized Lewis rats during experimental allergic encephalomyelitis. J Autoimmun 1996, 9:167-174
12. Arnon R, Teitelbaum D: On the existence of suppressor cells. Int Arch Allergy Immunol 1993, 100:2-7
13. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Hafler DA: Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis. J Exp Med 1995, 182:1-12
14. Leonard JP, Waldburger KE, Goldman SJ: Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 1995, 181:381-386
15. Wolf SF, Temple PA, Kobayashi M, Young D, Dieig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kellcher K, Hermann SH, Clark SC, Azzoni L, Chan SH, Trinchien G, Perussia B: Cloning of cDNA for natural killer stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991, 146:3074-3081
16. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 1993, 177:1199-1204
17. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 1993, 177:1797-1802
18. Segal BM, Shevach EM: IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med 1996, 184:771-775
19. Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahine A: Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993, 240:417-422
20. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995, 13:251-276
21. Orange JS, Wolf SF, Biron CA: Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994, 152:1253-1264
22. Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman CG, Steinman L: Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 1993, 365:642-644
23. Crisi GM, Santambrogio L, Hochwald GM, Smith SR, Carlino JA, Thorbecke GJ: Staphylococcal enterotoxin B and tumor-necrosis factor-α-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-β and interleukin-10. Eur J Immunol 1995, 25:3035-3040
24. Polman CH, Matthaei I, de Groot CJA, Koetsier JC, Sminia T, Dijkstra CD: Low-dose cyclosporine A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat. J Neuroimmunol 1988, 17:209-216
25. Kojima K, Berger T, Lassmann H, Hinze Selch D, Zhang Y, Gehrmann J, Reske K, Wekerle H, Linington C: Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 β molecule, a calcium binding protein of astroglia. J Exp Med 1994, 180:817-829
26. Newcombe J, Cuzner ML: Characterisation of adult human glial cells in vitro. Adv Biosci 1986, 61:419-420
27. Waldburger KE, Hastings RC, Schaub RG, Goldman SJ, Leonard JP: Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Am J Pathol 1996, 148:375-382
28. + T cells as a mechanism for remission from experimental allergic encephalomyelitis. J Neuroimmunol 1993, 44:193-198
29. + encephalitogenic T cells. Eur J Immunol 1994, 24:2609-2617
30. Tabi Z, McCombe PA, Pender MP: Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int Immunol 1995, 7:967-973
31. Cross AH, Cannella B, Brosnan CF, Raine CS: Hypothesis: antigen-specific T cells prime central nervous system endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination. J Neuroimmunol 1991, 33:237-244
32. Bauer J, Ruuls SR, Huitinga I, Dijkstra CD: The role of macrophage subpopulations in autoimmune disease of the central nervous system. J Histochem 1996, 28:83-97
33. MacPhee IAM, Antoni FA, Mason DW: Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989, 169:431-445
34. Adda DH, Beraud E, Depieds R: Evidence for suppressor cells in Lewis rats experimental allergic encephalomyelitis. Eur J Immunol 1977, 7:620-623
35. McFarlin DE, Blank SE, Kibler RF: Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol 1974, 113:712-715
36. Keith AB: Sex differences in Lewis rats in the incidence of experimental allergic encephalomyelitis. Nature 1978, 272:824-825
37. Waxman FJ, Bergman RK, Munoz JJ: Abrogation of resistance to the reinduction of experimental allergic encephalomyelitis by pertussigen. Cell Immunol 1982, 72:375-383
38. MacPhee IA, Mason DW: Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease. J Neuroimmunol 1990, 27:9-19
39. Killen JA, Swanborg RH: Regulation of experimental allergic encephalomyelitis. IV. Further characterization of post recovery suppressor cells. J Neuroimmunol 1982, 3:159-166
40. + suppressor cells inhibit the function of the effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-β. J Immunol 1991, 146:1163-1168
41. + (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur J Immunol 1988, 18:495-502
42. Voorthuis JAC, Uitdehaag BM, de Groot CJA, Goede PH, Van Der Meide PH, Dijkstra CD: Suppression of experimental allergic encephalomyelitis by intra-ventricular administration of IFN-γ in Lewis rats. Clin Exp Immunol 1990, 81:183-188
43. Billiau A, Heremans H, Vandekerekhove F, Dijkmans R, Sobis H, Meulepas E, Carton H: Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J Immunol 1988, 140:1506-1510
44. Sheffler LA, Wink DA, Melillo G, Cox GW: Exogenous nitric oxide regulates IFN-γ plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages. J Immunol 1995, 155:886-894
45. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz JP: Synthesis of nitric oxide in CMS glial cells. Trends Neurosci 1993, 16:323-328
46. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE: Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993, 151:2132-2141
47. Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merrill JE: Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 1994, 61:575-585
48. Okuda Y, Nakatsuji Y, Fujimura H, Esumi H, Ogura T, Yanagihara T, Sakoda S: Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol 1995, 62:103-112
49. Cross AH, Misko TP, Line RF, Hickey WF, Trotter JL, Tilton RG: Aminoguanidine, an inhibitor of nitric oxide synthase, ameliorates experimental autoimmune en- cephalomyelitis in SJL mice. J Clin Invest 1994, 93:2684-2690
50. Brosnan CF, Bornstein MB, Bloom BR: The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 1981, 126:614-620
51. Schapiro RT, Van den Noort S, Scheinberg L: The current management of multiple sclerosis. Ann NY Acad Sci 1984, 436:425-434